New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study indicates possible link between chronic stress and Alzheimer's disease

Study indicates possible link between chronic stress and Alzheimer's disease

by Karolinska InstitutetCredit: Unsplash/CC0 Public DomainResearchers from Karolinska Institutet have publisheda studyinAlzheimer's Research & Therapythat addresse
Neurology March 02,2024
Study indicates possible link between chronic stress and Alzheimer's disease

Study indicates possible link between chronic stress and Alzheimer's disease

by Karolinska InstitutetCredit: Unsplash/CC0 Public DomainResearchers from Karolinska Institutet have publisheda studyinAlzheimer's Research & Therapythat addresse
Neurology March 02,2024
Antibody therapy inspired by patient case reduces tau tangles in a preclinical model of Alzheimer's disease

Antibody therapy inspired by patient case reduces tau tangles in a preclinical model of Alzheimer's disease

by Mass General BrighamCredit: Pixabay/Pete Linforth.A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alz
Neurology March 02,2024
Antibody therapy inspired by patient case reduces tau tangles in a preclinical model of Alzheimer's disease

Antibody therapy inspired by patient case reduces tau tangles in a preclinical model of Alzheimer's disease

by Mass General BrighamCredit: Pixabay/Pete Linforth.A team led by researchers from Mass General Brigham reports promising results for a monoclonal antibody that takes aim at a new target for Alz
Neurology March 02,2024
Exercise-induced hormone irisin may reduce Alzheimer's disease plaque and tangle pathology in the brain

Exercise-induced hormone irisin may reduce Alzheimer's disease plaque and tangle pathology in the brain

by Massachusetts General HospitalCredit: Rice UniversityResearchers who previously developed the first 3D human cell culture models of Alzheimer's disease (AD) that displays two major hallmar
Neurology March 02,2024
Exercise-induced hormone irisin may reduce Alzheimer's disease plaque and tangle pathology in the brain

Exercise-induced hormone irisin may reduce Alzheimer's disease plaque and tangle pathology in the brain

by Massachusetts General HospitalCredit: Rice UniversityResearchers who previously developed the first 3D human cell culture models of Alzheimer's disease (AD) that displays two major hallmar
Neurology March 02,2024
Midlife insomnia may increase risk for later dementia

Midlife insomnia may increase risk for later dementia

by Lori SolomonInsomnia and short sleep duration in middle age increase the risk for dementia, according to a study published in the September issue ofAge and Ageing.Xiao Tan, from the Zhejiang
Neurology March 02,2024
Midlife insomnia may increase risk for later dementia

Midlife insomnia may increase risk for later dementia

by Lori SolomonInsomnia and short sleep duration in middle age increase the risk for dementia, according to a study published in the September issue ofAge and Ageing.Xiao Tan, from the Zhejiang
Neurology March 02,2024
Study highlight potential links between COVID-19 and Alzheimer's disease

Study highlight potential links between COVID-19 and Alzheimer's disease

by WileyCredit: Pixabay/Pete Linforth.The various neurological symptoms that patients with COVID-19 have experienced suggest that viral infections may increase the risk of neurodegeneration, whic
Neurology March 02,2024
Study highlight potential links between COVID-19 and Alzheimer's disease

Study highlight potential links between COVID-19 and Alzheimer's disease

by WileyCredit: Pixabay/Pete Linforth.The various neurological symptoms that patients with COVID-19 have experienced suggest that viral infections may increase the risk of neurodegeneration, whic
Neurology March 02,2024
Both high and low HDL cholesterol tied to increased risk of dementia

Both high and low HDL cholesterol tied to increased risk of dementia

by American Academy of NeurologyCredit: CC0 Public DomainHaving either high or low levels of high-density lipoprotein (HDL) cholesterol, or "good" cholesterol, is tied to a small increa
Neurology March 02,2024
Both high and low HDL cholesterol tied to increased risk of dementia

Both high and low HDL cholesterol tied to increased risk of dementia

by American Academy of NeurologyCredit: CC0 Public DomainHaving either high or low levels of high-density lipoprotein (HDL) cholesterol, or "good" cholesterol, is tied to a small increa
Neurology March 02,2024
Researchers connect Alzheimer's-associated genetic variants with brain cell function

Researchers connect Alzheimer's-associated genetic variants with brain cell function

by University of North Carolina at Chapel Hill School of MedicineRepresentative immunofluorescence staining of microglia-specific marker IBA-1. Credit:Nature Genetics(2023). DOI: 10.1
Neurology March 02,2024
Researchers connect Alzheimer's-associated genetic variants with brain cell function

Researchers connect Alzheimer's-associated genetic variants with brain cell function

by University of North Carolina at Chapel Hill School of MedicineRepresentative immunofluorescence staining of microglia-specific marker IBA-1. Credit:Nature Genetics(2023). DOI: 10.1
Neurology March 02,2024
Q&A: Validating an MRI biomarker for early onset Alzheimer's disease

Q&A: Validating an MRI biomarker for early onset Alzheimer's disease

by Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainAlexandra Touroutoglou, Ph.D., and Bradford Dickerson, MD, neuroscientists in the department of Neurology at Massachusetts Genera
Q & A March 02,2024
Q&A: Validating an MRI biomarker for early onset Alzheimer's disease

Q&A: Validating an MRI biomarker for early onset Alzheimer's disease

by Massachusetts General HospitalCredit: Pixabay/CC0 Public DomainAlexandra Touroutoglou, Ph.D., and Bradford Dickerson, MD, neuroscientists in the department of Neurology at Massachusetts Genera
Q & A March 02,2024
Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer's disease is safe

Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer's disease is safe

by Atrium Health Wake Forest BaptistSenescent neurons are represented by areas of blue, red and white. Senescent cells are old, sick cells that cannot properly repair themselves and don't die
Neurology March 02,2024
Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer's disease is safe

Phase I clinical trial shows treatment designed to clear senescent cells in Alzheimer's disease is safe

by Atrium Health Wake Forest BaptistSenescent neurons are represented by areas of blue, red and white. Senescent cells are old, sick cells that cannot properly repair themselves and don't die
Neurology March 02,2024
Risk for dementia reduced in association with antihypertensive use

Risk for dementia reduced in association with antihypertensive use

by Elana GotkineAntihypertensive use is associated with a reduced risk for dementia compared with untreated hypertension, according to research published online Sept. 12 inJAMA Network Open.Matt
Neurology March 02,2024
Risk for dementia reduced in association with antihypertensive use

Risk for dementia reduced in association with antihypertensive use

by Elana GotkineAntihypertensive use is associated with a reduced risk for dementia compared with untreated hypertension, according to research published online Sept. 12 inJAMA Network Open.Matt
Neurology March 02,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com